Multiple Rising Oral Doses of BI 201335 NA for Hepatitis
ID Number 07-0859Principal Investigator(s)
Department(s) or Division(s)
The study is designed to find out if the new drug is effective, safe, and to determine the level of the drug in the patient's body (pharmacokinetics).
Douglas Dieterich, MD
Recruiting Patients: No